Published in Oncol Lett on January 27, 2015
Insulin-like growth factor 2 mRNA-binding protein-3 as a marker for distinguishing between cutaneous squamous cell carcinoma and keratoacanthoma. Int J Oncol (2016) 0.75
Prognostic value of high IMP3 expression in solid tumors: a meta-analysis. Onco Targets Ther (2017) 0.75
The new World Health Organization classification of lung tumours. Eur Respir J (2001) 6.91
RNA-binding IMPs promote cell adhesion and invadopodia formation. EMBO J (2006) 2.34
The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells. J Biol Chem (2005) 1.94
Methylation markers of early-stage non-small cell lung cancer. PLoS One (2012) 1.65
External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma. Cancer (2008) 1.45
Combination of quantitative IMP3 and tumor stage: a new system to predict metastasis for patients with localized renal cell carcinomas. Clin Cancer Res (2008) 1.31
Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival. BMC Cancer (2010) 1.22
Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual. Cancer (2003) 1.21
Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer. Reproduction (2005) 1.21
IMP3, a new biomarker to predict progression of cervical intraepithelial neoplasia into invasive cancer. Am J Surg Pathol (2011) 1.13
IMP3 can predict aggressive behaviour of lung adenocarcinoma. Diagn Pathol (2012) 1.03
IMP3 distinguishes uterine serous carcinoma from endometrial endometrioid adenocarcinoma. Am J Clin Pathol (2010) 1.01
RNA-binding protein insulin-like growth factor mRNA-binding protein 3 (IMP-3) promotes cell survival via insulin-like growth factor II signaling after ionizing radiation. J Biol Chem (2011) 0.98
Diagnostic utility of IMP3 in segregating metastatic melanoma from benign nevi in lymph nodes. Mod Pathol (2009) 0.88
Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinoma. Eur Urol (2013) 0.84
Insulin-like growth factor-II mRNA-binding protein 3 predicts a poor prognosis for colorectal adenocarcinoma. Oncol Lett (2013) 0.84
The correlation between insulin-like growth factor II mRNA binding protein 3 expression in hepatocellular carcinoma and prognosis. Hepatogastroenterology (2013) 0.84
Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores. BMC Cancer (2010) 0.81
[Expression of insulin-like growth factor 2 mRNA-binding protein 3 expression and analysis of prognosis in the patients with lung squamous cell carcinoma]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi (2013) 0.79
Changes in insulin like growth factors, myostatin and vascular endothelial growth factor in rat musculus latissimus dorsi by poly-3-hydroxybutyrate implants. J Physiol Pharmacol (2009) 0.79
Insulin-like growth factor II messenger RNA-binding protein 3 expression in gastrointestinal mesenchymal tumors. Hum Pathol (2013) 0.79
IMP3 expression in urothelial carcinomas of the urinary bladder. Turk Patoloji Derg (2011) 0.79